CIPAMI-study: clopidogrel administered prehospital to improve primary PCI in patients with acute myocardial infarction.

Trial Profile

CIPAMI-study: clopidogrel administered prehospital to improve primary PCI in patients with acute myocardial infarction.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2012

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms CIPAMI
  • Most Recent Events

    • 29 Aug 2010 Results have been presented at ESC Congress 2010: Annual Congress of the European Society of Cardiology.
    • 26 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Jan 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top